From Proteomics to Diagnosis: Biomarker Discovery in Tuberculosis Research.

Curr Med Chem

NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102629, China.

Published: October 2024

Tuberculosis (TB) is a leading cause of death from a single infectious disease worldwide. Early and accurate diagnosis is advantageous for timely detection and prompt treatment, thereby reducing the risk of disease transmission, which is essential for effective TB control. Biomarkers provide a valuable resource for TB diagnosis. Proteomic technologies have emerged as a powerful tool in biomarker discovery. In this perspective, we explore how proteomic technologies contribute to the discovery of TB diagnostic biomarkers. We also address the challenges and discuss prospective methods to augment the performance of biomarkers in diagnosing TB.

Download full-text PDF

Source
http://dx.doi.org/10.2174/0109298673346264241008110105DOI Listing

Publication Analysis

Top Keywords

biomarker discovery
8
proteomic technologies
8
proteomics diagnosis
4
diagnosis biomarker
4
discovery tuberculosis
4
tuberculosis tuberculosis
4
tuberculosis leading
4
leading death
4
death single
4
single infectious
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!